Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NutraSweet is a global leader in the production of high-intensity sweeteners and a pioneer in the food science industry. The company gained worldwide recognition for the development and commercialization of aspartame, a low-calorie sugar substitute that revolutionized the diet food and beverage market. Originally a division of G.D. Searle & Co. and later owned by Monsanto, NutraSweet now operates as a private entity with a focus on advanced sweetening solutions. Its current portfolio includes neotame and sustainable, plant-based stevia extracts marketed under the NutraSweet Natural brand. The company's products are essential ingredients for manufacturers looking to reduce sugar content while maintaining taste profiles. NutraSweet continues to serve the global food, beverage, and pharmaceutical sectors by addressing consumer demand for healthier, low-calorie alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NutraSweet.